Immunotherapy for haematologic malignancies with CD19-directed chimeric antigen receptor T cells has been extremely profitable at eradicating most cancers however is related to acute neurotoxicity in ∼40% of sufferers. This neurotoxicity correlates with systemic cytokine launch syndrome, endothelial activation and disruption of endothelial integrity, nevertheless it stays unclear how these mechanisms work together and the… Continue reading